Telix Pharmaceuticals reported AUD33.24M in EBITDA for its fiscal semester ending in June of 2025.


Ebitda Change Date
Cochlear AUD 323M 24.1M Dec/2024
CSL USD 3.23B 1.52B Dec/2024
Integral Diagnostics AUD 46.27M 3.52M Jun/2024
Mayne Pharma AUD -65761000 45.24M Jun/2024
Medical Developments International AUD 1.78M 3.78M Dec/2024
Mesoblast -41273000 20.33M Jun/2024
Neuren Pharmaceuticals AUD 176.7M 166.79M Dec/2024
Pacific Edge NZD -13968000 332K Sep/2024
Paradigm Biopharmaceuticals AUD -5859230 3.79M Dec/2024
Polynovo AUD 2.86M 1.12M Jun/2024
PYC Therapeutics AUD -25596250 3.68M Dec/2024
Ramsay Health Care AUD 1.02B 22.3M Dec/2024
ResMed USD 530.86M 57.71M Jun/2025
Sonic Healthcare AUD 839.07M 51.09M Dec/2024